查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1716362

2032 年牙科麻醉剂市场预测：按麻醉剂类型、给药途径、应用、最终用户和地区进行的全球分析

Dental Anesthetics Market Forecasts to 2032 - Global Analysis By Type of Anesthetic (Local Anesthetics, General Anesthetics and Sedatives), Route of Administration (Injectable and Topical), Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球牙科麻醉剂市场预计在 2025 年达到 21 亿美元，到 2032 年将达到 31 亿美元，预测期内的复合年增长率为 5.7%。

牙科麻醉剂是麻木口腔某些区域的药物，可减轻牙科治疗期间的疼痛和不适。根据患者的需要和麻醉剂的强度，可以使用局部麻醉、局部麻醉剂全身麻醉剂。牙科麻醉剂常用于根管治疗、填充和拔牙，它可以阻断某些区域的神经讯号，使牙医能够安全舒适地进行手术，而不会给患者带来疼痛或不适。

根据世界卫生组织（WHO）的数据，全球约有35亿人患有口腔疾病，其中约20亿人恆牙患有龋齿，5.14亿儿童乳牙患有龋齿。

牙科疾病增加

龋齿和牙周病等牙科疾病的盛行率不断上升，大大推动了牙科麻醉剂市场的发展。随着口腔卫生知识的增加，越来越多的人接受牙科治疗，包括补牙和拔牙等常规程序。这些手术需要有效的麻醉方法来确保患者的舒适。此外，年轻人牙科疾病的增加也推高了麻醉剂的需求。全球牙科护理的可近性和诊断技术的进步也极大地推动了市场的成长。

潜在的副作用和併发症

牙科麻醉剂行业由于可能产生的副作用以及应用相关的问题而面临困难。对过敏反应、毒性和长时间麻木的担忧可能会阻止患者选择特定的麻醉剂。此外，不当的给药可能会导致神经损伤和系统性问题，引起医疗保健提供者的担忧。这些风险需要密切监测和专家管理，并限制某些麻醉剂的广泛使用。此外，患者对麻醉相关不适的担忧可能会阻碍市场扩张。

尖端麻醉剂和输送系统的开发

由于麻醉剂配方和输送技术的进步，预计将实现显着成长。创新技术包括电脑控制局部麻醉输送 (CCLAD) 设备，可提高注射精度并减轻疼痛。此外，对更耐用、更安全的配方的研究正在提高功效，同时最大限度地减少不良影响。这些进步是为了满足人们对非侵入性牙科治疗（尤其是美容和儿科护理）日益增长的需求。此外，製造商和医疗保健专业人员之间的伙伴关係正在推动客製化麻醉解决方案的创新，以满足不同患者的需求。

严格的监管核准流程

牙科麻醉剂核准的严格监管程序阻碍了市场扩张。製造商必须遵守复杂的法令遵循，以确保其产品安全有效，有时会导致产品发布延迟或价格上涨。此外，地区法规的差异也阻碍了全球分销计划。这些障碍限制了较小营业单位的创新，因为它们可能缺乏进行全面临床试验和监管提交所需的资源。此外，加强对不利影响的审查会使核准过程变得更加困难。

COVID-19的影响：

由于封锁期间牙科治疗数量减少，COVID-19 疫情对牙科麻醉剂业务产生了不利影响。全球供应链问题影响了麻醉剂的供应。此外，由于患者出于健康考量而不愿去诊所，需要麻醉的常规手术也减少了。疫情后的復苏得益于人们对口腔健康的认识提高以及人口结构的变化增加了对牙科护理的需求。此外，远距牙科和微创技术的进步预计将在整个预测期内推动市场扩张。

预计在预测期内局部麻醉剂市场将成长至最大的份额。

由于局部麻醉剂剂广泛应用于填充和拔牙等常见的牙科手术中，预计在预测期内将占据最大的市场占有率。局部麻醉剂的优点是对全身的副作用较小，并且比全身麻醉更经济。Lidocaine因其安全性和有效性仍然是局部麻醉的标准。此外，单齿麻醉装置等技术创新提高了麻醉的精确度和病患在麻醉过程中的舒适度。无痛治疗的需求日益增长，推动了市场成长，使局部麻醉剂成为现代牙科的重要组成部分。

预计门诊手术中心 (ASC) 部分在预测期内将实现最高的复合年增长率。

在预测期内，门诊手术中心 (ASC) 部分预计将呈现最高的成长率，因为与传统医院环境相比，它们能够以更低的价格有效地提供门诊手术。门诊手术中心 (ASC) 正在满足日益增长的微创手术需求，以满足患者对便利性的偏好并提供更快的康復。此外，医疗技术的进步使得 ASC 能够在麻醉下安全地进行复杂的手术。在许多国家，ASC 与医疗保健提供者之间的合作越来越受到认可，以优化营运并提高护理品质。

比最大的地区

在预测期内，由于人们对口腔健康的认识不断提高以及对牙科保健基础设施的大量投资，预计北美将占据最大的市场占有率。该地区受益于先进的诊断技术和日益增长的需要在麻醉下定期进行牙科手术的老年人口。此外，对美容牙科日益增长的需求也大大推动了市场的成长。推动创新的关键营业单位的参与确保透过策略伙伴关係和符合当地需求的产品推出实现持续成长。

复合年增长率最高的地区：

在预测期内，由于公众口腔卫生意识的增强和都市化进程的加快，预计亚太地区将呈现最高的复合年增长率。在中国和印度等新兴国家，可支配收入的增加使得人们能够更享受现代牙科保健服务。此外，政府努力改善医疗保健基础设施，使人们更方便地获得需要麻醉的有效治疗。该地区的中等收入阶层正在扩大，对采用最新麻醉方法的美容牙科的需求也日益增长。

免费客製化服务：

订阅此报告的客户可享有以下免费自订选项之一：

  • 公司简介
    • 对其他市场公司（最多 3 家公司）进行全面分析
    • 主要企业的SWOT分析（最多3家公司）
  • 地理细分
    • 根据客户兴趣对主要国家市场进行估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 研究范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 限制因素
  • 机会
  • 威胁
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球牙科麻醉剂市场（依麻醉剂类型划分）

  • 局部麻醉剂
    • 酰胺类局部麻醉剂
      • Lidocaine
      • Articaine
      • Prilocaine
      • Bupivacaine
      • Mepivacaine
      • 其他酰胺类麻醉剂
    • 酯类局部麻醉剂
      • 普鲁卡因
      • Benzocaine
      • 丁卡因
      • 其他酯类麻醉剂
  • 全身麻醉
    • 吸入全身麻醉剂
    • 静脉全身麻醉
  • 镇静剂
    • 氧化亚氮
    • 口服镇静剂
    • 静脉镇静

6. 全球牙科麻醉剂市场（依给药途径划分）

  • 注射
  • 局部的
    • 凝胶
    • 喷
    • 修补

7. 全球牙科麻醉剂市场（按应用）

  • 修復牙科
  • 牙周病学
  • 口腔外科
  • 义肢
  • 植入
  • 儿童牙科
  • 美容牙科
  • 其他用途

8. 全球牙科麻醉剂市场（依最终用户）

  • 牙医诊所
  • 医院
  • 门诊手术中心（ASC）
  • 牙科研究所

9. 全球牙科麻醉剂市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司概况

  • Dentsply Sirona
  • Septodont
  • Pierrel SpA
  • Henry Schein Inc.
  • Hikma Pharmaceuticals PLC
  • 3M Company
  • Primex Pharmaceuticals
  • Aspen Group
  • Laboratorios Inibsa
  • Laboratorios Normon
  • Cetylite Inc.
  • Zeyco
  • Milestone Scientific
  • Centrix, Inc.
  • Crosstex International, Inc.
  • HANSAmed Limited
Product Code: SMRC29173

According to Stratistics MRC, the Global Dental Anesthetics Market is accounted for $2.1 billion in 2025 and is expected to reach $3.1 billion by 2032, growing at a CAGR of 5.7% during the forecast period. Dental anesthetics are drugs that reduce pain and suffering during dental treatments by numbing particular parts of the mouth. Depending on the patient's demands and the intensity of the surgery, they can be topical, local, or general anesthetics. Dental anesthetics, which are frequently used in root canals, fillings, and extractions, block nerve signals in specific regions, enabling dentists to treat patients securely, comfortably, and without causing them any pain or discomfort.

According to data from the World Health Organization, oral diseases affected approximately 3.5 billion people globally, with around 2 billion suffering from caries of permanent teeth and 514 million children affected by caries of primary teeth.

Market Dynamics:

Driver:

Increasing prevalence of dental diseases

The increasing incidence of dental illnesses, including caries and periodontal diseases, significantly propels the dental anesthetics market. As knowledge of oral health rises, more individuals are pursuing dental treatments, encompassing regular operations such as fillings and extractions. These procedures require efficient anesthetic methods to guarantee patient comfort. Furthermore, the increasing prevalence of dental problems in youngsters enhances the demand for anesthetics. Global accessibility to dental care and advancements in diagnostic technology also significantly boost market growth.

Restraint:

Potential side effects and complications

The dental anesthetics industry encounters difficulties stemming from possible adverse effects and issues linked to its application. Concerns such as allergic reactions, toxicity, and extended numbness may dissuade patients from selecting specific anesthetic agents. Moreover, inappropriate administration may result in nerve injury or systemic issues, heightening concerns among healthcare providers. These dangers require rigorous oversight and expert management, constraining the broad utilization of certain anesthetics. Furthermore, patient anxiety concerning anesthesia-related discomfort may hinder market expansion.

Opportunity:

Development of advanced anesthetic agents and delivery systems

Advancements in anesthetic formulations and delivery technologies provide substantial growth prospects. Innovations include computer-controlled local anesthesia delivery (CCLAD) devices that enhance precision and reduce pain during injections. Furthermore, investigations into more durable and safer formulations improve efficacy while minimizing unwanted effects. These advancements address the increasing demand for non-invasive dental treatments, especially in cosmetic dentistry and pediatric care. Moreover, partnerships between manufacturers and healthcare professionals foster innovation in anesthetic solutions customized for various patient requirements.

Threat:

Stringent regulatory approval processes

Strict regulatory procedures for the approval of dental anesthetics hinder market expansion. Manufacturers must traverse intricate compliance regulations to guarantee product safety and efficacy, sometimes delaying product launches and escalating prices. Furthermore, discrepancies in rules among regions hamper worldwide distribution plans. These obstacles constrain innovation among smaller entities that may lack the resources for comprehensive clinical trials and regulatory applications. Additionally, increased examination of negative impacts exacerbates the approval process.

Covid-19 Impact:

The Covid-19 outbreak adversely affected the dental anesthetics business because of a decline in dental treatments during lockdowns. Global supply chain issues impacted the availability of anesthetic drugs. Additionally, patients' reluctance to attend clinics due to health concerns led to a decrease in regular procedures requiring anesthetics. Post-pandemic recovery is due to increased awareness of oral health and demographic changes that increase the need for dental care. Moreover, throughout the forecast period, we expect advancements in teledentistry and minimally invasive techniques to enhance market expansion.

The local anesthetics segment is expected to be the largest during the forecast period

The local anesthetics segment is expected to account for the largest market share during the forecast period owing to their extensive application in common dental procedures, such as fillings and extractions. They provide benefits including fewer systemic adverse effects and economic efficiency relative to general anesthesia. Lidocaine continues to be the benchmark for local anesthesia, owing to its safety and efficacy. Furthermore, technological innovations such as single-tooth anesthetic devices improve accuracy and patient comfort during delivery. The rising need for painless treatments propels market growth, rendering local anesthetics essential in contemporary dentistry.

The ambulatory surgical centers (ASCs) segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the ambulatory surgical centers (ASCs) segment is predicted to witness the highest growth rate owing to its efficacy in providing outpatient operations at reduced prices compared to conventional hospital environments. Ambulatory Surgical Centers (ASCs) address the increasing need for less invasive procedures that offer expedited recovery, in accordance with patient preferences for convenience. Furthermore, innovations in medical technology allow ASCs to conduct intricate surgeries securely under anesthesia. Collaborations between ASCs and healthcare providers optimize operations and improve care quality, thereby increasing their acceptance in many countries.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share owing to heightened awareness of oral health and significant investments in dental care infrastructure. The area benefits from sophisticated diagnostic technology and an increasing elderly population necessitating regular dental procedures under anesthesia. Furthermore, the increasing demand for cosmetic dentistry substantially drives market growth. The involvement of pivotal entities fostering innovation guarantees continuous growth via strategic partnerships and product introductions customized to regional demands.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR due to heightened public awareness regarding oral health and rapid urbanization. Increasing disposable incomes facilitate access to modern dental care services in rising economies such as China and India. Moreover, governmental actions that advance healthcare infrastructure development improve access to effective treatments necessitating anesthesia. The expanding middle class in the region is increasing the need for cosmetic dentistry utilizing contemporary anesthetic methods.

Key players in the market

Some of the key players in Dental Anesthetics Market include Dentsply Sirona, Septodont, Pierrel S.p.A., Henry Schein Inc., Hikma Pharmaceuticals PLC, 3M Company, Primex Pharmaceuticals, Aspen Group, Laboratorios Inibsa, Laboratorios Normon, Cetylite Inc., Zeyco, Milestone Scientific, Centrix, Inc., Crosstex International, Inc., and HANSAmed Limited.

Key Developments:

In March 2025, Dentsply Sirona, the world's largest diversified manufacturer of professional dental products and technologies, and Rapid Shape, a leading innovator in German-engineered dental 3D printing technology are pleased to announce a collaboration to validate the Lucitone Digital Print Denture workflow and material system on Rapid Shape's 3D printing solutions for digital denture manufacturing.

In May 2024, Laboratorios Inibsa Launched Prestoject(R) Dental Syringes for enhanced precision in administering anesthesia. Prestoject(R) Dental Syringes are meticulously designed to provide a solution that sets a new standard for comfortable and successful dental anaesthesia.

In August 2023, 3M announced it has completed the sale of certain assets from its dental local anesthetic portfolio, based in Seefeld, Germany, to Pierrel S.p.A. ("Pierrel"), a global provider of services for the pharmaceutical industry, for a purchase price of $70 million, subject to closing and other adjustments. These local anesthetic products, sold primarily in Europe and Asia, include products sold under the Ubistesin(TM), Xylestesin(TM) and Mepivastesin(TM) brands as well as related syringe and needle products. These were formerly a part of the dental materials business in 3M's Oral Care Solutions Division.

Type of Anesthetics Covered:

  • Local Anesthetics
  • General Anesthetics
  • Sedative

Route of Administrations Covered:

  • Injectable
  • Topical

Applications Covered:

  • Restorative Dentistry
  • Periodontics
  • Oral Surgery
  • Prosthodontics
  • Implantology
  • Pediatric Dentistry
  • Cosmetic Dentistry
  • Other Applications

End Users Covered:

  • Dental Clinics
  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Dental Research Institutes

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Dental Anesthetics Market, By Type of Anesthetic

  • 5.1 Introduction
  • 5.2 Local Anesthetics
    • 5.2.1 Amide-based Local Anesthetics
      • 5.2.1.1 Lidocaine
      • 5.2.1.2 Articaine
      • 5.2.1.3 Prilocaine
      • 5.2.1.4 Bupivacaine
      • 5.2.1.5 Mepivacaine
      • 5.2.1.6 Other Amide-based Anesthetics
    • 5.2.2 Ester-based Local Anesthetics
      • 5.2.2.1 Procaine
      • 5.2.2.2 Benzocaine
      • 5.2.2.3 Tetracaine
      • 5.2.2.4 Other Ester-based Anesthetics
  • 5.3 General Anesthetics
    • 5.3.1 Inhalation General Anesthetics
    • 5.3.2 Intravenous General Anesthetics
  • 5.4 Sedative
    • 5.4.1 Nitrous Oxide
    • 5.4.2 Oral Sedatives
    • 5.4.3 Intravenous Sedatives

6 Global Dental Anesthetics Market, By Route of Administration

  • 6.1 Introduction
  • 6.2 Injectable
  • 6.3 Topical
    • 6.3.1 Gels
    • 6.3.2 Sprays
    • 6.3.3 Patches

7 Global Dental Anesthetics Market, By Application

  • 7.1 Introduction
  • 7.2 Restorative Dentistry
  • 7.3 Periodontics
  • 7.4 Oral Surgery
  • 7.5 Prosthodontics
  • 7.6 Implantology
  • 7.7 Pediatric Dentistry
  • 7.8 Cosmetic Dentistry
  • 7.9 Other Applications

8 Global Dental Anesthetics Market, By End User

  • 8.1 Introduction
  • 8.2 Dental Clinics
  • 8.3 Hospitals
  • 8.4 Ambulatory Surgical Centers (ASCs)
  • 8.5 Dental Research Institutes

9 Global Dental Anesthetics Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Dentsply Sirona
  • 11.2 Septodont
  • 11.3 Pierrel S.p.A.
  • 11.4 Henry Schein Inc.
  • 11.5 Hikma Pharmaceuticals PLC
  • 11.6 3M Company
  • 11.7 Primex Pharmaceuticals
  • 11.8 Aspen Group
  • 11.9 Laboratorios Inibsa
  • 11.10 Laboratorios Normon
  • 11.11 Cetylite Inc.
  • 11.12 Zeyco
  • 11.13 Milestone Scientific
  • 11.14 Centrix, Inc.
  • 11.15 Crosstex International, Inc.
  • 11.16 HANSAmed Limited

List of Tables

  • Table 1 Global Dental Anesthetics Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Dental Anesthetics Market Outlook, By Type of Anesthetic (2024-2032) ($MN)
  • Table 3 Global Dental Anesthetics Market Outlook, By Local Anesthetics (2024-2032) ($MN)
  • Table 4 Global Dental Anesthetics Market Outlook, By Amide-based Local Anesthetics (2024-2032) ($MN)
  • Table 5 Global Dental Anesthetics Market Outlook, By Lidocaine (2024-2032) ($MN)
  • Table 6 Global Dental Anesthetics Market Outlook, By Articaine (2024-2032) ($MN)
  • Table 7 Global Dental Anesthetics Market Outlook, By Prilocaine (2024-2032) ($MN)
  • Table 8 Global Dental Anesthetics Market Outlook, By Bupivacaine (2024-2032) ($MN)
  • Table 9 Global Dental Anesthetics Market Outlook, By Mepivacaine (2024-2032) ($MN)
  • Table 10 Global Dental Anesthetics Market Outlook, By Other Amide-based Anesthetics (2024-2032) ($MN)
  • Table 11 Global Dental Anesthetics Market Outlook, By Ester-based Local Anesthetics (2024-2032) ($MN)
  • Table 12 Global Dental Anesthetics Market Outlook, By Procaine (2024-2032) ($MN)
  • Table 13 Global Dental Anesthetics Market Outlook, By Benzocaine (2024-2032) ($MN)
  • Table 14 Global Dental Anesthetics Market Outlook, By Tetracaine (2024-2032) ($MN)
  • Table 15 Global Dental Anesthetics Market Outlook, By Other Ester-based Anesthetics (2024-2032) ($MN)
  • Table 16 Global Dental Anesthetics Market Outlook, By General Anesthetics (2024-2032) ($MN)
  • Table 17 Global Dental Anesthetics Market Outlook, By Inhalation General Anesthetics (2024-2032) ($MN)
  • Table 18 Global Dental Anesthetics Market Outlook, By Intravenous General Anesthetics (2024-2032) ($MN)
  • Table 19 Global Dental Anesthetics Market Outlook, By Sedative (2024-2032) ($MN)
  • Table 20 Global Dental Anesthetics Market Outlook, By Nitrous Oxide (2024-2032) ($MN)
  • Table 21 Global Dental Anesthetics Market Outlook, By Oral Sedatives (2024-2032) ($MN)
  • Table 22 Global Dental Anesthetics Market Outlook, By Intravenous Sedatives (2024-2032) ($MN)
  • Table 23 Global Dental Anesthetics Market Outlook, By Route of Administration (2024-2032) ($MN)
  • Table 24 Global Dental Anesthetics Market Outlook, By Injectable (2024-2032) ($MN)
  • Table 25 Global Dental Anesthetics Market Outlook, By Topical (2024-2032) ($MN)
  • Table 26 Global Dental Anesthetics Market Outlook, By Gels (2024-2032) ($MN)
  • Table 27 Global Dental Anesthetics Market Outlook, By Sprays (2024-2032) ($MN)
  • Table 28 Global Dental Anesthetics Market Outlook, By Patches (2024-2032) ($MN)
  • Table 29 Global Dental Anesthetics Market Outlook, By Application (2024-2032) ($MN)
  • Table 30 Global Dental Anesthetics Market Outlook, By Restorative Dentistry (2024-2032) ($MN)
  • Table 31 Global Dental Anesthetics Market Outlook, By Periodontics (2024-2032) ($MN)
  • Table 32 Global Dental Anesthetics Market Outlook, By Oral Surgery (2024-2032) ($MN)
  • Table 33 Global Dental Anesthetics Market Outlook, By Prosthodontics (2024-2032) ($MN)
  • Table 34 Global Dental Anesthetics Market Outlook, By Implantology (2024-2032) ($MN)
  • Table 35 Global Dental Anesthetics Market Outlook, By Pediatric Dentistry (2024-2032) ($MN)
  • Table 36 Global Dental Anesthetics Market Outlook, By Cosmetic Dentistry (2024-2032) ($MN)
  • Table 37 Global Dental Anesthetics Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 38 Global Dental Anesthetics Market Outlook, By End User (2024-2032) ($MN)
  • Table 39 Global Dental Anesthetics Market Outlook, By Dental Clinics (2024-2032) ($MN)
  • Table 40 Global Dental Anesthetics Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 41 Global Dental Anesthetics Market Outlook, By Ambulatory Surgical Centers (ASCs) (2024-2032) ($MN)
  • Table 42 Global Dental Anesthetics Market Outlook, By Dental Research Institutes (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.